Levamisole enhances global and differential leukocyte numbers in peripheral blood of dogs with ehrlichiosis

Authors : Dhagma Renata Denis SOUZA, Andréia Lima Tomé MELO, Lívia Saab MURARO, Daniel Moura AGUIAR, Deijanira ALBUQUERQUE

Pages : 647-652

Doi:10.3906/tar-1211-72

View : 21 | Download : 11

Publication Date : 0000-00-00

Article Type : Research Paper

Abstract :Ehrlichiosis is a disease caused by Ehrlichia, a genus of obligatory intracellular bacteria that parasitize leukocytes and provoke several hematological alterations. In this work, we investigated the effect of levamisole associated with doxycycline on peripheral leukocytes in dogs PCR-positive for ehrlichial DNA. Twenty-one Ehrlichia-infected dogs were randomly distributed in 2 groups: a control group insert ignore into journalissuearticles values(n = 10); and a levamisole-treated group insert ignore into journalissuearticles values(n = 11);. Blood samples were collected from each animal for hematological and DNA analysis both before initiating the experiment and 5 days later. All dogs were treated with doxycycline insert ignore into journalissuearticles values(10 mg/kg body weight);, cimetidine insert ignore into journalissuearticles values(5 mg/kg of body weight);, and fluid therapy for 5 consecutive days. In addition to receiving antibiotic therapy, the levamisole-treated dogs received a single subcutaneous injection insert ignore into journalissuearticles values(1 mg/kg body weight); of levamisole on the first day of the experiment. The results show that levamisole associated with doxycycline significantly enhanced global leukocyte, lymphocyte, and monocyte numbers in the peripheral blood of dogs with ehrlichiosis. Those data suggest that the combination of doxycycline with levamisole may improve canine ehrlichiosis treatment through impairment of leukopenia, which is not controlled by antibiotic therapy alone.
Keywords : Key words Ehrlichia canis, ehrlichiosis, levamisole